Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled study of liraglutide for long-term weight management in adults with obesity or overweight
CTR20251619Phase 3Active
- Sponsor
- Heze Pharma
- Start
- Jun 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in obesity, Overweight, sponsored by Heze Pharma. Started Jun 2025; status: active.
02
Drugs
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20251619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251619.